However, that study did not discriminate between non-invasive and invasive bladder cancers; therefore, CYP2A6 contribution to the risk of developing invasive bladder cancer phenotype could not be clearly determined. This evidence concerns the gene CYP2A6 and urinary bladder carcinoma.